Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in England.
Woods B, Kearns B, Schmitt L, Jankovic D, Rothery C, Harnan S, Hamilton J, Scope A, Ren S, Bojke L, Wilcox M, Hope W, Leonard C, Howard P, Jenkins D, Ashworth A, Bentley A, Sculpher M.
Woods B, et al.
Appl Health Econ Health Policy. 2025 Jan;23(1):5-17. doi: 10.1007/s40258-024-00924-x. Epub 2024 Nov 30.
Appl Health Econ Health Policy. 2025.
PMID: 39616299
Free article.